Quest Diagnostics Shares Up 27.7% Since SmarTrend's Buy Recommendation (DGX)

SmarTrend identified an Uptrend for Quest Diagnostics (NYSE:DGX) on February 18th, 2016 at $65.35. In approximately 6 months, Quest Diagnostics has returned 27.69% as of today's recent price of...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.